轩竹生物-B(02575)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02575 轩竹生物-B

休市中 02-13 16:08:07

63.200

-2.300

-3.51%

最高64.000	最低60.000	成交量39.40万
今开64.000	昨收65.500	日振幅6.11%
总市值327.38亿	流通市值101.56亿	总股本5.18亿
成交额2,431万	换手率0.25%	流通股本1.61亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02575","market":"HK","secType":"STK","nameCN":"轩竹生物-B","latestPrice":63.2,"timestamp":1770970087182,"preClose":65.5,"halted":0,"volume":394007,"delay":0,"changeRate":-0.03511450381679385,"floatShares":160701996,"shares":518000000,"eps":-1.234826,"marketStatus":"休市中","change":-2.3,"latestTime":"02-13 16:08:07","open":64,"high":64,"low":60,"amount":24305274,"amplitude":0.061069,"askPrice":63.2,"askSize":500,"bidPrice":62.5,"bidSize":3500,"shortable":0,"etf":0,"ttmEps":-1.178,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771205400000},"marketStatusCode":7,"adr":0,"listingDate":1760457600000,"exchange":"SEHK","adjPreClose":65.5,"openAndCloseTimeList":[[1770946200000,1770955200000],[1770958800000,1770969600000]],"volumeRatio":1.0052681240260228,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02575/wiki","defaultTab":"wiki","newsList":[{"id":"2611425156","title":"轩竹生物-B(02575)获纳入恒生综合指数 有望成为港股通标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2611425156","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611425156?lang=zh_cn&edition=full","pubTime":"2026-02-13 19:26","pubTimestamp":1770982006,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2月13日，恒生指数公司宣布截至2025年12月31日之恒生指数系列季度检讨结果，其中轩竹生物-B(02575)获纳入恒生综合指数。变动将于2026年3月6日(星期五)收市后实施并于2026年3月9日(星期一)起生效，届时沪深交易所会相应调整港股通可投资标的范围。据中金研报，轩竹生物有可能被调入港股通，因其满足了包括市值、流动性和上市时间等在内的一系列标准。2025年12月7日，国家医疗保障局公布2025年国家医保药品目录调整结果，轩竹生物自主研发的1类创新药、CDK4/6抑制剂吡洛西利片成功纳入目录，为晚期乳腺癌患者带来医保报销新福利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK4585","VXUS","02575","VT","BK4588","HSCI"],"gpt_icon":0},{"id":"2610891405","title":"轩竹生物-B盘中异动 下午盘股价大跌5.44%报64.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610891405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610891405?lang=zh_cn&edition=full","pubTime":"2026-02-12 13:35","pubTimestamp":1770874512,"startTime":"0","endTime":"0","summary":"2026年02月12日下午盘13时35分，轩竹生物-B股票出现异动，股价大幅跳水5.44%。截至发稿，该股报64.300港元/股，成交量35.65万股，换手率0.22%，振幅6.18%。资金方面，该股资金流入1121.31万港元，流出1071.88万港元。轩竹生物-B股票所在的生物技术行业中，整体跌幅为0.21%。轩竹生物-B公司简介：轩竹生物科技股份有限公司是一家主要从事生物制药业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602121335129540d8e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602121335129540d8e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02575"],"gpt_icon":0},{"id":"2610681325","title":"轩竹生物-B盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610681325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610681325?lang=zh_cn&edition=full","pubTime":"2026-02-09 10:24","pubTimestamp":1770603859,"startTime":"0","endTime":"0","summary":"2026年02月09日早盘10时24分，轩竹生物-B股票出现波动，股价快速拉升5.05%。截至发稿，该股报72.800港元/股，成交量4.4万股，换手率0.03%，振幅5.48%。轩竹生物-B股票所在的生物技术行业中，整体涨幅为1.77%。其相关个股中，歌礼制药-B、北海康成-B、中国抗体-B涨幅较大，振幅较大的相关个股有北海康成-B、奥星生命科技、旺山旺水-B，振幅分别为10.03%、8.75%、8.34%。轩竹生物-B公司简介：轩竹生物科技股份有限公司是一家主要从事生物制药业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209102419a6e400de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209102419a6e400de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02575"],"gpt_icon":0},{"id":"2609510330","title":"轩竹生物-B盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609510330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609510330?lang=zh_cn&edition=full","pubTime":"2026-02-06 14:07","pubTimestamp":1770358072,"startTime":"0","endTime":"0","summary":"2026年02月06日下午盘14时07分，轩竹生物-B股票出现波动，股价急速拉升5.19%。截至发稿，该股报69.950港元/股，成交量28.9605万股，换手率0.18%，振幅7.44%。轩竹生物-B股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，歌礼制药-B、诺诚健华、亿腾嘉和涨幅较大，振幅较大的相关个股有歌礼制药-B、创胜集团-B、诺诚健华，振幅分别为17.31%、13.75%、13.51%。轩竹生物-B公司简介：轩竹生物科技股份有限公司是一家主要从事生物制药业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206140752a6da37ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206140752a6da37ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02575"],"gpt_icon":0},{"id":"2609514892","title":"四环医药仿制药触底中，轩竹生物成功分拆，创新药进入收获期，惠升生物布局糖尿病全管线也迎","url":"https://stock-news.laohu8.com/highlight/detail?id=2609514892","media":"第一上海","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609514892?lang=zh_cn&edition=full","pubTime":"2026-02-06 13:14","pubTimestamp":1770354864,"startTime":"0","endTime":"0","summary":"公司正处于从传统仿制药向“医美+创新药”双轮驱动的战略转型期。预计到2028年，医美板块收入将达到40亿元左右，复合增速超过50%。考虑到公司全面领先的医美管线布局及其未来的盈利能力，建议投资者重点关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206133039a4832565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206133039a4832565&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","BK1515","06978","00460","BK1574","BK1191","BK1600","02575"],"gpt_icon":0},{"id":"1177899849","title":"轩竹生物（02575）2026年1月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1177899849","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177899849?lang=zh_cn&edition=full","pubTime":"2026-02-05 17:27","pubTimestamp":1770283639,"startTime":"0","endTime":"0","summary":"2026年2月5日，轩竹生物科技股份有限公司（港交所股票代码：02575）发布2026年1月股份变动月报，披露截至1月31日的股本情况。公告显示，该公司注册股本仍包括160,701,996股H股及357,245,794股未上市股份，总计517,947,790股，与上期保持一致。\n报告期内未发生新增发行、购回或注销，H股及未上市股份数量无变化，公共持股量维持上市规则要求的24.96%。同时，公告未披露任何股份期权、可换股票据及其他股权激励计划的变动信息。\n截至2026年1月31日，轩竹生物股本维持稳定。公司确认遵守香港联交所相关上市规则及法律规定，公告由联席公司秘书何成明签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":0},{"id":"2609801302","title":"轩竹生物-B盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609801302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609801302?lang=zh_cn&edition=full","pubTime":"2026-02-05 09:40","pubTimestamp":1770255606,"startTime":"0","endTime":"0","summary":"2026年02月05日早盘09时40分，轩竹生物-B股票出现波动，股价大幅下跌5.23%。截至发稿，该股报67.050港元/股，成交量1.7万股，换手率0.01%，振幅5.23%。资金方面，该股资金流入3.53万港元，流出107.573万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。轩竹生物-B股票所在的生物技术行业中，整体跌幅为1.05%。轩竹生物-B公司简介：轩竹生物科技股份有限公司是一家主要从事生物制药业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205094006a47ddf9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205094006a47ddf9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575","BK1191"],"gpt_icon":0},{"id":"2604113631","title":"轩竹生物-B盘中异动 急速下挫5.17%报67.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604113631?lang=zh_cn&edition=full","pubTime":"2026-01-19 09:43","pubTimestamp":1768786999,"startTime":"0","endTime":"0","summary":"2026年01月19日早盘09时43分，轩竹生物-B股票出现异动，股价急速下跌5.17%。截至发稿，该股报67.000港元/股，成交量2.4万股，换手率0.01%，振幅4.25%。轩竹生物-B股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，晶泰控股、科笛-B、中生北控生物科技涨幅较大，振幅较大的相关个股有基石药业-B、百奥赛图-B、复宏汉霖，振幅分别为8.02%、7.02%、6.37%。轩竹生物-B公司简介：轩竹生物科技股份有限公司是一家主要从事生物制药业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119094319953d4303&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119094319953d4303&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575","BK1191"],"gpt_icon":0},{"id":"2603683674","title":"轩竹生物-B盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603683674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603683674?lang=zh_cn&edition=full","pubTime":"2026-01-13 09:42","pubTimestamp":1768268579,"startTime":"0","endTime":"0","summary":"2026年01月13日早盘09时42分，轩竹生物-B股票出现波动，股价大幅拉升5.19%。截至发稿，该股报68.850港元/股，成交量3.25万股，换手率0.02%，振幅4.35%。轩竹生物-B股票所在的生物技术行业中，整体涨幅为1.08%。其相关个股中，荣昌生物、基石药业-B、药明康德涨幅较大，振幅较大的相关个股有帝王国际投资、瑞博生物-B、昭衍新药，振幅分别为8.60%、7.89%、7.61%。轩竹生物-B公司简介：轩竹生物科技股份有限公司是一家主要从事生物制药业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011309425997a185bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011309425997a185bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575","BK1191"],"gpt_icon":0},{"id":"2602770370","title":"轩竹生物-B盘中异动 急速拉升5.08%报62.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602770370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602770370?lang=zh_cn&edition=full","pubTime":"2026-01-09 11:34","pubTimestamp":1767929671,"startTime":"0","endTime":"0","summary":"2026年01月09日临近午盘11时34分，轩竹生物-B股票出现异动，股价快速上涨5.08%。截至发稿，该股报62.000港元/股，成交量4.55万股，换手率0.03%，振幅8.56%。资金方面，该股资金流入89.4775万港元，流出117.778万港元。轩竹生物-B股票所在的生物技术行业中，整体跌幅为0.33%。轩竹生物-B公司简介：轩竹生物科技股份有限公司是一家主要从事生物制药业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109113431a7057892&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109113431a7057892&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02575"],"gpt_icon":0},{"id":"2601355360","title":"港股异动 | 轩竹生物-B(02575)再涨超7% 吡洛西利片医保落地 有望显著提升吡洛西利可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=2601355360","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601355360?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:08","pubTimestamp":1767856137,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，轩竹生物-B(02575)再涨超7%，截至发稿，涨6.95%，报58.45港元，成交额1076.71万港元。消息面上，2025年12月7日，国家医疗保障局公布2025年国家医保药品目录调整结果，轩竹生物自主研发的1类创新药、CDK4/6抑制剂吡洛西利片成功纳入目录，为晚期乳腺癌患者带来医保报销新福利。2026年1月1日，吡洛西利国家医保正式执行，有望显著提升吡洛西利的可及性，切实减轻患者经济负担。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02575"],"gpt_icon":0},{"id":"1110094646","title":"轩竹生物科技（02575）2025年12月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1110094646","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110094646?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:36","pubTimestamp":1767775007,"startTime":"0","endTime":"0","summary":"轩竹生物科技股份有限公司于2026年1月7日发布截至2025年12月31日的股份变动月报表。报表显示，公司的股本结构在2025年12月期间没有任何新发行或回购注销活动，股本维持稳定。公司截至本报告期末的已发行普通股包括160,701,996股H股及357,245,794股未上市股份，总计517,947,790股。其中，H股及未上市股份在12月均无新增发行、回购或注销，期末与期初持平。本月报由联席公司秘书何成明签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":0},{"id":"2601884779","title":"港股异动 | 轩竹生物-B(02575)早盘涨超6% 创新药吡洛西利2026元旦医保落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2601884779","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601884779?lang=zh_cn&edition=full","pubTime":"2026-01-07 09:55","pubTimestamp":1767750903,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，轩竹生物-B早盘涨超6%，截至发稿，涨2.36%，报52.05港元，成交额299.05万港元。消息面上，2026年1月1日，吡洛西利国家医保正式执行！2025年12月7日，国家医疗保障局公布2025年国家医保药品目录调整结果，轩竹生物自主研发的1类创新药、CDK4/6抑制剂吡洛西利片成功纳入目录，为晚期乳腺癌患者带来医保报销新福利。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389645.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02575","BK1161","06978","159992","BK1191"],"gpt_icon":0},{"id":"2601000737","title":"轩竹生物-B(02575)：徐艳君获委任为总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2601000737","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601000737?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:49","pubTimestamp":1767606570,"startTime":"0","endTime":"0","summary":"智通财经APP讯，轩竹生物-B(02575)发布公告，经公司提名委员会推荐，徐艳君女士已获委任为公司总经理，自2026年1月5日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02575"],"gpt_icon":0},{"id":"2600054767","title":"轩竹生物-B(02575)：李嘉逵拟辞任执行董事及总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2600054767","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600054767?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:42","pubTimestamp":1767343320,"startTime":"0","endTime":"0","summary":"智通财经APP讯，轩竹生物-B(02575)发布公告，李嘉逵博士辞任本公司执行董事及总经理，以投放更多时间于其他业务承担。为确保企业管治及董事会运作顺利过渡，李博士承诺会继续忠实及勤勉尽责地履行执行董事职责。辞任仅于本公司股东大会委任新执行董事加入董事会后生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"轩竹生物-B(02575)：李嘉逵拟辞任执行董事及总经理","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02575"],"gpt_icon":0},{"id":"2600527056","title":"轩竹生物-B盘中异动 早盘股价大跌7.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600527056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600527056?lang=zh_cn&edition=full","pubTime":"2026-01-02 09:53","pubTimestamp":1767318781,"startTime":"0","endTime":"0","summary":"2026年01月02日早盘09时53分，轩竹生物-B股票出现波动，股价大幅下挫7.94%。截至发稿，该股报64.900港元/股，成交量1.454万股，换手率0.01%，振幅7.02%。轩竹生物-B股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，中国抗体-B、拨康视云-B、君实生物涨幅较大，振幅较大的相关个股有北海康成-B、科笛-B、拨康视云-B，振幅分别为9.77%、8.59%、7.31%。轩竹生物-B公司简介：轩竹生物科技股份有限公司是一家主要从事生物制药业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010209530197a0efb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010209530197a0efb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575","BK1191"],"gpt_icon":0},{"id":"1165476322","title":"一周港股牛熊榜 | 东航周涨17%领跑，力勤资源、新华保险强势！曹操出行、商汤深度回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1165476322","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165476322?lang=zh_cn&edition=full","pubTime":"2025-12-19 17:49","pubTimestamp":1766137794,"startTime":"0","endTime":"0","summary":"月内，货邮周转量上升13.30%。据悉，力勤资源是全球领先的镍龙头企业，全面覆盖镍产业链。12月14日，又一利好政策出台。12月9日晚间，中国人寿发布公告称，今年截至11月30日总保费已突破7000亿元。不过，相关公告消息未止曹操出行股价周二续跌。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","02643","02577","03858","02575","02245","06666","01336","00670","00020"],"gpt_icon":1},{"id":"1150760712","title":"港股异动｜生物医药股上扬，药捷安康涨超17%，昭衍新药涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150760712","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150760712?lang=zh_cn&edition=full","pubTime":"2025-12-17 10:50","pubTimestamp":1765939813,"startTime":"0","endTime":"0","summary":"轩竹生物涨超5%，银诺医药涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"22a0e03e703ab82b83863db78ab69d04","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","02591","06127","02575"],"gpt_icon":0},{"id":"1176090511","title":"一周港股牛熊榜 |  长飞光纤光缆周内飙34%，AI算力基建热潮推动光通信需求；轩竹生物周升28%，轩悦宁进入医保目录；第一拖拉机周升21%获高盛看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1176090511","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176090511?lang=zh_cn&edition=full","pubTime":"2025-12-12 18:12","pubTimestamp":1765534337,"startTime":"0","endTime":"0","summary":"高速光模块、光纤光缆及相关配套设备的需求随之水涨船高。$轩竹生物-B$ 本周累升28.11%，轩悦宁进入医保目录，两款肿瘤产品年内密集获批轩竹生物近日宣布，创新药轩悦宁首次纳入国家基本医保药品目录。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f31f9c4b7b746092dc00ca030c9a8d42","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一周港股牛熊榜 |  长飞光纤光缆周内飙34%，AI算力基建热潮推动光通信需求；轩竹生物周升28%，轩悦宁进...","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127","00038","HSCEI","02643","01618","00108","02575","02591","HSI","HSTECH","09678","01072","06869"],"gpt_icon":1},{"id":"2590265255","title":"港股异动 | 轩竹生物-B(02575)涨超20%再破顶 轩悦宁进入医保目录 两款肿瘤产品年内密集获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2590265255","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590265255?lang=zh_cn&edition=full","pubTime":"2025-12-12 10:09","pubTimestamp":1765505371,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，轩竹生物-B涨超20%，高见93.05港元，再创上市新高。消息面上，轩竹生物近日宣布，创新药轩悦宁首次纳入国家基本医保药品目录。智通财经APP在《两款肿瘤产品年内密集获批 从产品力视角看轩竹生物创新价值》中指出，医药行业价值回归产品力的背景下，轩竹生物2025年两款肿瘤新药获批，完成创新价值关键兑现。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f31f9c4b7b746092dc00ca030c9a8d42","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02575"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xuanzhubio.com","stockEarnings":[{"period":"1week","weight":-0.088},{"period":"1month","weight":-0.0834},{"period":"3month","weight":-0.0117},{"period":"6month","weight":4.4483},{"period":"ytd","weight":-0.1035}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0187},{"period":"6month","weight":0.0513},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0365}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"轩竹生物科技股份有限公司是一家主要从事生物制药业务的中国公司。该公司主要从事研发、生产及商业化创新药的业务，专注于消化、肿瘤和非酒精性脂肪性肝炎（NASH）等多个治疗领域。该公司主要产品包括KBP-3571、XZP-3287及XZP-3621。该公司主要在中国国内开展业务。","exchange":"SEHK","name":"轩竹生物-B","nameEN":"XUANZHUBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"轩竹生物-B(02575)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供轩竹生物-B(02575)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"轩竹生物-B,02575,轩竹生物-B股票,轩竹生物-B股票老虎,轩竹生物-B股票老虎国际,轩竹生物-B行情,轩竹生物-B股票行情,轩竹生物-B股价,轩竹生物-B股市,轩竹生物-B股票价格,轩竹生物-B股票交易,轩竹生物-B股票购买,轩竹生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"轩竹生物-B(02575)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供轩竹生物-B(02575)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}